- |||||||||| Trial primary completion date: Efficacy Study in Patients With Acne Vulgaris. (clinicaltrials.gov) - Mar 20, 2017
P2, N=300, Active, not recruiting, Recruiting --> Active, not recruiting Trial primary completion date: Dec 2016 --> Mar 2017
- |||||||||| tazarotene topical / Generic mfg.
Trial primary completion date: A Study Comparing Tazarotene Cream 0.1% to TAZORAC (clinicaltrials.gov) - Mar 20, 2017 P3, N=1110, Recruiting, Trial primary completion date: Dec 2016 --> Mar 2017 Trial primary completion date: Mar 2017 --> Aug 2017
- |||||||||| finasteride / Generic mfg.
Trial primary completion date: Finasteride Treatment of Severe Nodulocystic Acne (clinicaltrials.gov) - Feb 7, 2017 P2, N=180, Recruiting, Recruiting --> Active, not recruiting Trial primary completion date: Dec 2016 --> Jul 2017
- |||||||||| berdazimer sodium (SB204) / Sato Pharma, Novan
Clinical: Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris (clinicaltrials.gov) - Jan 4, 2017 P1, N=18, Active, not recruiting, Recruiting --> Completed | N=100 --> 60 | Trial primary completion date: Sep 2016 --> Dec 2016 | Recruiting --> Completed Trial primary completion date: Dec 2016 --> Jun 2017
- |||||||||| adapalene / Generic mfg.
Enrollment closed, Trial primary completion date: A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments (clinicaltrials.gov) - Dec 23, 2016 P4, N=130, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2016 --> Apr 2017
- |||||||||| berdazimer sodium (SB204) / Sato Pharma, Novan
Clinical: P3 Study in Acne Comparing Once Daily SB204 and Vehicle (clinicaltrials.gov) - Dec 22, 2016 P3, N=1306, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2016 --> Apr 2017 Recruiting --> Active, not recruiting
|